SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending as investors debate its path to profitability amidst recent news of its acquisition of Homebuyer.com to integrate mortgage services and AI into its real estate platform. While some view the current price weakness as a tax-loss selling opportunity for long-term accumulation and a potential rebound in the new year, others express frustration over the sustained downtrend and question the immediate impact of strategic moves on its financial performance. Community sentiment remains deeply divided between those anticipating a significant turnaround and those fearing further declines.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is a hot topic due to a proposed merger with Applied Digital's cloud business, forming ChronoScale, an AI platform. This move has ignited significant community debate, with some anticipating a massive surge on AI momentum and a tight float. However, many current shareholders voice strong skepticism, highlighting their projected 3% ownership in the new entity as a highly unfavorable outcome.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech Inc. ($MTEX) is experiencing heightened investor interest driven by its extremely low public float, leading to significant community speculation about a potential short squeeze and a parabolic breakout. While a strong bullish contingent anticipates substantial gains, others caution against a possible pump-and-dump given the rapid price action without immediate news. This discussion reflects a broader trend of retail traders targeting thinly traded micro-cap stocks for high-volatility, momentum-driven rallies.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is drawing significant community attention, with active discussions focusing on its evolving utility, including the LitVM airdrop and Omnichain developments for yield generation. While many express strong long-term conviction in its 'digital silver' role, traders are also closely watching key support levels and technical indicators amidst ongoing market volatility.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to promising preliminary data from its FLAMINGO-01 breast cancer trial, which reported an 80% recurrence rate reduction, coupled with extended insider share lock-ups until 2026. The community is buzzing about the potential for a significant short squeeze, fueled by extremely high cost-to-borrow rates and the firm's long-term commitment to shareholder value without immediate dilution.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is a key topic as it discontinues the RAMP 203 lung cancer trial to pivot resources toward the highly promising KRAS G12D inhibitor, VS-7375, following recent management changes aimed at accelerating growth. This move has polarized the community, with many seeing it as a strategic financial decision to focus on the most impactful pipeline asset, while others voice frustration over the resulting stock decline and concerns about market manipulation.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas (GASS) is trending amidst highly polarized community sentiment, with proponents highlighting its potential as a meme coin, sometimes linking it to PEPE's creator, and advocating to 'HODL' for significant gains. This bullish outlook is countered by strong skepticism from others who label it as 'junk' or a 'scam,' questioning its long-term viability and price action.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is generating significant buzz as investors eagerly await crucial FDA decisions for its Relacorilant treatment for Cushing Syndrome, alongside recent promising Phase 3 data for ovarian cancer. The community is actively debating its substantial long-term pipeline potential, fueling intense speculation around a short squeeze despite recent volatile price action.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Lipocine is trending following positive pivotal study results for its oral postpartum depression candidate, LPCN 1154, which met bioequivalence and paves the way for an NDA filing. The community is actively discussing the company's significantly undervalued market capitalization and diverse pipeline, with strong interest in its potential for partnerships or acquisition. This progress, combined with a low share float, is generating considerable buzz about future growth across its various therapeutic areas including women's health, liver disease, and metabolic disorders.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is currently a hot topic driven by excitement over newly announced high-grade silver discoveries and the broader surge in precious metal prices, especially with reports of impending silver export restrictions from China. The community is actively debating the stock's future, with many bullish investors highlighting strategic institutional accumulation and the company's extensive resource potential for a significant squeeze. Conversely, others warn of previous dilution and a lack of current revenue amidst an anticipated securities offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FFC Nobody here as with other CEFs 
 
But look at the massive rip in $IGR this past month! And even $JPC, another preferred stock leveraged CEF, did pretty well  
 
This is a laggard. But leveraged. Money will return to beaten down CEFS with bonds and preferred shares especially as financial conditions continue to loosen and effects of it felt. Narrowing the discount to NAV to closer to average at least. And lower treasury yields should drive people back to other high yielding assets such as these  
 
Good holdings. In. 
 
$PDI $PDO

El Jefe

Personalizit 1

StockTwits For Android 

Eyore

StockTwits Web

Pimco Dynamic Fund

Flaherty & Crumrine/Claymore Preferred Securities Income Fund Inc.

ING Clarion Global Real Estate Income Fund

Nuveen Multi-Strategy Income & Growth Fund

PIMCO Dynamic Income Fund

 Nobody here as with other CEFs 
 
But look at the massive rip in 

, another preferred stock leveraged CEF, did pretty well  
 
This is a laggard. But leveraged. Money will return to beaten down CEFS with bonds and preferred shares especially as financial conditions continue to loosen and effects of it felt. Narrowing the discount to NAV to closer to average at least. And lower treasury yields should drive people back to other high yielding assets such as these  
 
Good holdings. In. 
 


I&#39;ve kept the bulk of the positions I added in $HQH $BUI $EXG $IGR $JPC.

Eaton Vance Tax-Managed Global 

H&Q Healthcare Investors

Blackrock Utility And Infrastructure Trust

I've kept the bulk of the positions I added in 

$BUI has better 10 year cumulative return than $PDI 👀

 has better 10 year cumulative return than 

@Eyore  are toy invest in $PDI ? Or $BUI ?

StockTwits for iOS

@hadababymama in BUI and a few others. PDI has done exceptionally well but its holdings all over the place. BUI is concentrated exposure to beaten down utilities

 in BUI and a few others. PDI has done exceptionally well but its holdings all over the place. BUI is concentrated exposure to beaten down utilities